Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Hodgkin Disease 50 Lymphoma 45 Testicular Neoplasms 13 Teratoma 12 HIV Infections 12 Acquired Immunodeficiency Syndrome 11 Lymphoma, Large B-Cell, Diffuse 10 Lymphoma, Non-Hodgkin 9 Head and Neck Neoplasms 8 Endodermal Sinus Tumor 8 Testicular Germ Cell Tumor 7 Sarcoma, Kaposi 7 Neoplasms 7 Carcinoma, Embryonal 7 Seminoma 6 Lymphoma, Large-Cell, Immunoblastic 6 Lymphoma, Follicular 6 Ovarian Neoplasms 5 Ovarian Germ Cell Cancer 5 Recurrence 4 Neoplasms, Germ Cell and Embryonal 4 Neoplasm Metastasis 4 Carcinoma, Squamous Cell 4 Vulvar Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Breast Neoplasms 3 Teratoma, Testicular 2 Skin Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Drug-Related Side Effects and Adverse Reactions 2

Interventions

Etoposide 3 Carboplatin 3 tremelimumab 1 etoposide phosphate 1 durvalumab 1 Surgical Procedures, Operative 1 Spinal Puncture 1 Specimen Handling 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 Radiotherapy 1 Photochemotherapy 1 Paclitaxel 1 Magnetic Resonance Spectroscopy 1 Ifosfamide 1 Granulocyte Colony-Stimulating Factor 1 Drug Therapy 1 Dihematoporphyrin Ether 1 Cyclophosphamide 1 Cisplatin 1 Bleomycin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Germinoma × Bleomycin × Clear all

NCT02782754 2016-05-25

Chemotherapy Plus Reduced Radiotherapy in Intracranial Germinoma

Samsung Medical Center

Phase 2 Unknown

Germinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡